Scott Rottinghaus
Chief Tech/Sci/R&D Officer at ENANTA PHARMACEUTICALS, INC.
Net worth: 353 022 $ as of 30/04/2024
Scott Rottinghaus active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 08/08/2022 | - |
Career history of Scott Rottinghaus
Former positions of Scott Rottinghaus
| Companies | Position | Start | End |
|---|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Training of Scott Rottinghaus
| Mayo Medical School | Doctorate Degree |
| University of Cambridge | Graduate Degree |
| Kansas State University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| 2 | |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Scott Rottinghaus
- Experience
